Retinoblastoma — Trials

Retinoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 8
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: Institut Curie
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04344652	Photoscreening for Retinoblastoma	withdrawn	N/A	0	Phoenix Children's HospitalOTHER	0	Sep 26, 2025	clinicaltrials
NCT00980551	Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma(RELRB1)	withdrawn	N/A	0	Children's Hospital Medical Center, CincinnatiOTHER	1	Mar 3, 2017	clinicaltrials